Preferred Name |
Ceftizoxime |
Synonyms |
Sodium, Ceftizoxime |
Definitions |
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
ID |
http://purl.bioontology.org/ontology/MESH/D015296 |
altLabel |
Sodium, Ceftizoxime SK&F 88373-2 Cefizox Salt, Ceftizoxime Monosodium SKF 88373 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))- Ceftizoxime Monosodium Salt SKF-88373 SK&F 883732 FK-749 FK 749 FR-13749 SKF88373 Monosodium Salt, Ceftizoxime Ceftizoxime Sodium FK749 FR13749 FR 13749 SK&F 88373 2 |
AQL |
AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
cui |
C0282391 C0007560 C0016636 C0701023 C0037237 C0037261 C0016187 |
DC |
1 |
definition |
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
DX |
19890101 |
HN |
89 |
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000528 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000652 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000600 http://purl.bioontology.org/ontology/MESH/Q000378 |
Inverse of RB |
C43C467DPE 0 26337D5X88 |
isa | |
LT |
TRD |
Machine permutation |
89 |
Mapped from |
http://purl.bioontology.org/ontology/MESH/C041950 http://purl.bioontology.org/ontology/MESH/C047445 http://purl.bioontology.org/ontology/MESH/C054692 http://purl.bioontology.org/ontology/MESH/C047444 http://purl.bioontology.org/ontology/MESH/C510184 http://purl.bioontology.org/ontology/MESH/C053268 http://purl.bioontology.org/ontology/MESH/C121334 http://purl.bioontology.org/ontology/MESH/C049934 |
MDA |
19880524 |
MMR |
20170524 |
MN |
D02.065.589.099.249.190.190.145 D02.886.665.074.190.190.145 D03.633.100.300.249.190.190.145 |
notation |
D015296 |
PA |
D000900 |
prefLabel |
Ceftizoxime |
RR |
68401-81-0 (Ceftizoxime) 26337D5X88 68401-82-1 (mono NA salt) |
TERMUI |
T044970 T359719 T044974 T044972 T044968 T044973 T044969 T044967 T044971 |
TH |
FDA SRS (2014) USP (19XX) US NL UNK (19XX) JAN (19XX) USAN (1980) NLM (1990) BAN (19XX) CA NLM (1999) INN (19XX) |
tui |
T109 T195 |
subClassOf |